Ranbaxy Laboratories spurted 6.88% at Rs 464.70 at 9:31 IST after the firm on Wednesday, 30 November 2011, received approval from the United States health regulator to launch the generic version of cholesterol lowering drug Lipitor in the US market.
IMPORTANT TAGS
STOCKS TO WATCH
STOCK ADVICE
NIFTY TECHNICAL
NIFTY ON CHART
STOCK TECHNICAL LEVEL
STOCKTIPZ
BUY CALL
NIFTY VIEW
SELL CALL
MARKET EYE
STOCK NEWS
corporate news
RESULT IMPACT
ADVICE
INFLATION
INVESTMENT BUY
DERIVATIVES NEWSLATER
IIP DATA
CREDIT POLICY
RUPEE
CORPORATE ACTION
ECONOMIC CALENDER
EVENTS
IPO
IMPORTANT DATA
TOP TEN TRADED STOCKS
INVESTORS WEEKLY
SALES NUMBER
MARKET RADAR
MARKET TIMINGS
NEW LISTING
SPECIAL REPORT
WEEKLY CORPORATE NEWS
WPI
0 comments:
Post a Comment
Let Us Know Your Opinion!